Durmab Trademark Details
Word Mark | Durmab |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Serial Number | 77135003 |
---|---|
Status Date | Monday, July 6, 2009 |
Filing Date | Monday, July 6, 2009 |
Attorney | Nadine P. Flynn |
Correspondent
Nadine P. Flynn
BRISTOL-MYERS SQUIBB COMPANY
Trademark Department
345 PARK AVE
NEW YORK NY 10154-0004
BRISTOL-MYERS SQUIBB COMPANY
Trademark Department
345 PARK AVE
NEW YORK NY 10154-0004
Case File Statements
Goods & Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Friday, March 23, 2007 |
Primary Code | 005 |
Trademark Timeline
-
Mar 20 2007Trademark application filed with USPTO
-
Mar 23 2007New Application Entered In Tram
-
Mar 24 2007Notice of Pseudo Mark Mailed
-
Apr 24 2007Assigned To Examiner
-
May 01 2007Non-Final Action Written
-
May 02 2007Non-Final Action Mailed
-
Nov 05 2007Paper Received
-
Dec 13 2007Amendment From Applicant Entered
-
Dec 13 2007Correspondence Received In Law Office
-
Dec 13 2007Assigned To Lie
-
Jan 02 2008Approved For Pub - Principal Register
-
Feb 04 2008Law Office Publication Review Completed
-
Feb 20 2008Notice of Publication
-
Mar 11 2008Published For Opposition
-
Jun 03 2008Noa Mailed - Sou Required From Applicant
-
Nov 17 2008Extension 1 Granted
-
Nov 17 2008Extension 1 Filed
-
Nov 17 2008Teas Extension Received
-
Jul 06 2009Abandonment Notice Mailed - No Use Statement Filed
-
Jul 06 2009Abandonment - No Use Statement Filed